Austin Flint murmur is a classic cardiac auscultatory finding defined as a low-pitched, mid-to-late diastolic rumble heard best at the cardiac apex in patients with severe, chronic aortic regurgitation^{1, 3}. First described by the American physician Austin Flint in 1862, this acoustic phenomenon occurs in the absence of any intrinsic structural disease of the mitral valve apparatus^{1, 4}. Instead, the murmur is a manifestation of functional mitral stenosis generated when the high-velocity retrograde regurgitant jet from the incompetent aortic valve impinges upon the anterior leaflet of the mitral valve, forcing it to partially close during mid-diastole while left ventricular filling is underway^{1, 2}. Recognizing this physical sign is vital for clinicians, as it serves as a bedside indicator of significant left ventricular volume overload and hemodynamic severity, prompting timely advanced echocardiographic evaluation and surgical intervention^{3, 4}.

Etiology & Risk Factors

• Severe Chronic Aortic Regurgitation: The fundamental hemodynamic prerequisite for generating an Austin Flint murmur is severe aortic valve incompetence, which creates a large regurgitant volume entering the left ventricle during diastole^{1, 3}.
• Valvular Pathologies Causing Aortic Regurgitation: Bicuspid aortic valve morphology, calcific aortic valve disease, infective endocarditis resulting in leaflet perforation or destruction, rheumatic heart disease, and myxomatous degeneration with leaflet prolapse¹.
• Aortic Root Pathologies: Annuloaortic ectasia, systemic hypertension, Marfan syndrome, Ehlers-Danlos syndrome, syphilitic aortitis, acute aortic dissection involving the sinotubular junction, and severe connective tissue disorders causing root dilation^{1, 4}.
• Predisposing Clinical States: Chronic systemic arterial hypertension that accelerates aortic root dilation, advanced age associated with degenerative valvular calcification, and a history of chest wall irradiation or inflammatory vasculitides (e.g., Takayasu arteritis)^{1, 3}.

Pathophysiology

The pathophysiology of the Austin Flint murmur centers on fluid dynamics and intracardiac pressure gradients across the left heart during diastole^{1, 2}. In patients with severe chronic aortic regurgitation, a substantial volume of blood flows backward from the aorta into the left ventricle throughout diastole. As the left ventricle fills from both the left atrium and the regurgitant aortic stream, two distinct fluid streams converge near the mitral valve orifice. The eccentric regurgitant jet from the incompetent aortic valve strikes the atrial surface of the anterior mitral valve leaflet. This mechanical impact forces the anterior leaflet toward the interventricular septum prematurely, narrowing the functional cross-sectional area of the mitral valve orifice. Consequently, forward blood flow from the left atrium must traverse a functionally narrowed channel, creating turbulent flow and a pressure gradient across the mitral valve during mid-to-late diastole. This turbulence produces the characteristic low-pitched, rumbling apical diastolic murmur. A key pathophysiological hallmark is that despite the functional narrowing mimicking rheumatic mitral stenosis, the mitral valve leaflets remain structurally normal and pliable, and an opening snap is characteristically absent because the valve does not abruptly halt during opening under high atrial pressure. Furthermore, in normal sinus rhythm, the atrial kick produces a presystolic accentuation of the murmur as active atrial contraction increases forward flow across the restricted orifice immediately before ventricular systole^{1, 3}.

Clinical Presentation & Classic Clinical Signs

• History & Cardinal Symptoms: Patients with severe aortic regurgitation severe enough to produce an Austin Flint murmur frequently present with symptoms of progressive left ventricular failure and low cardiac output. Cardinal complaints include exertional dyspnoea, orthopnoea, paroxysmal nocturnal dyspnoea, fatigue, palpitations, and anginal chest pain (which can occur even in the absence of coronary artery disease due to increased myocardial oxygen demand from ventricular hypertrophy and decreased subendocardial perfusion pressure during low diastolic blood pressure)^{1, 3}.
• Physical Examination & Named Clinical Signs: Auscultation reveals a decrescendo early diastolic murmur along the left sternal border characteristic of aortic regurgitation, accompanied by a low-pitched, rumbling mid-to-late diastolic murmur with presystolic accentuation localized strictly to the cardiac apex (Austin Flint murmur)^{1, 2}. Peripheral signs of severe chronic aortic regurgitation are invariably present, including bounding pulses (Corrigan pulse), head bobbing with each heartbeat (de Musset sign), capillary pulsations in the nail beds (Quincke sign), pistol-shot sounds over the femoral arteries (Traube sign), and a systolic and diastolic murmur heard over the femoral artery when compressed slightly (Duroziez sign)^{1, 3}.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Staging, Classification & Clinical Scoring Systems

Differential Diagnosis

Management & Treatment Protocol

• Initial Stabilization & Resuscitation: In acute presentations or decompensated chronic severe aortic regurgitation, immediate stabilization in an intensive care setting is mandatory. Administer supplemental oxygen, continuous telemetry, and invasive arterial pressure monitoring. Avoid bradycardia, as a slower heart rate prolongs diastole and increases the regurgitant volume across the incompetent aortic valve^{1, 3}.
• First-Line Medical / Pharmacological Therapy (with exact adult dosing): Vasodilator therapy is indicated for patients with severe chronic aortic regurgitation who have symptoms or left ventricular dysfunction and are awaiting surgery, or as chronic therapy in symptomatic patients unfit for operation.
  • ACE Inhibitors: Enalapril starting at 2.5 to 5 mg orally twice daily, titrated up to 10 to 20 mg orally twice daily as tolerated to maintain systolic blood pressure and reduce systemic vascular resistance.
  • ARBs: Losartan starting at 25 to 50 mg orally once daily, titrated up to 100 mg orally once daily if ACE inhibitors are not tolerated due to cough.
  • Dihydropyridine Calcium Channel Blockers: Nifedipine extended-release 30 to 60 mg orally once daily can be utilized for afterload reduction in hypertensive patients with aortic regurgitation^{1, 3}.
• Surgical / Interventional Indications: Definitive treatment for severe aortic regurgitation manifesting with an Austin Flint murmur is surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) in selected high-risk surgical candidates. Indications include all symptomatic patients (Stage D), asymptomatic patients with left ventricular ejection fraction less than 50% (Stage C2), or patients undergoing cardiac surgery for other indications (such as coronary artery bypass grafting or ascending aortic aneurysm repair)^{1, 3}.

Complications & Prognosis

• Key Acute and Chronic Complications: Progressive left ventricular eccentric hypertrophy transitioning to decompensated heart failure, malignant ventricular arrhythmias, sudden cardiac death, infective endocarditis, and acute pulmonary edema^{1, 3}.
• Mortality and Morbidity Data: Asymptomatic patients with normal left ventricular function experience a low annual mortality rate of less than 3% per year. However, once symptoms develop or left ventricular systolic dysfunction ensues without surgical intervention, mortality increases dramatically, exceeding 10% to 20% per year^{1, 3}.
• Prognostic Factors: Long-term prognosis post-valve replacement is highly favorable when surgery is performed before the onset of irreversible myocardial damage or severe left ventricular systolic dysfunction (ejection fraction remaining above 50% and left ventricular end-systolic dimension less than 50 mm)^{1, 3}.